TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
TRIV was delisted on the 3rd of February, 2016.
41 hedge funds and large institutions have $169M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 2 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more funds holding
Funds holding: 41 → 41 (0)
7% less capital invested
Capital invested by funds: $181M → $169M (-$12.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.28M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$2.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.67M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$756K |
| 5 |
State Street
Boston,
Massachusetts
|
+$527K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$5.24M |
| 2 |
Millennium Management
New York
|
-$257K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$94.1K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$51.3K |
| 5 |
JP Morgan Chase
New York
|
-$16.7K |
TRIV Hedge Fund Activity: Q4 2014 in Review
41 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q4 2014, worth a combined $169M — down 6.9% from $181M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TRIV positions and 2 closed out — a net gain of 1 holder — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $3.28M. The largest seller was Deerfield Management, cutting an estimated $5.24M.
- 41 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $169M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q4 2014, down 6.9% quarter-over-quarter.
- 3 funds opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q4 2014 and 2 closed out, a net change of +1 holder.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q4 2014 was Wellington Management Group, an estimated $3.28M added.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK seller in Q4 2014 was Deerfield Management, an estimated $5.24M sold.
Based on aggregated 13F filings for Q4 2014.